StockDuty ← Dashboard Aug 26, 2026 05:43 AM ET
CatalystFDA/Bio

JAZZ PHARMACEUTICALS PLC (JAZZ) DISCUSSES FDA APPROVAL AND COMMERCIAL LAUNCH OF ZIIHERA FOR FIRST-LINE HER2-POSITIVE GEA - SLIDESHOW - SEEKINGALPHA

FDA approval and commercial launch of Zihera mark key regulatory and revenue catalysts for Jazz.

FDA approval and commercial launch of Zihera mark key regulatory and revenue catalysts for Jazz.
Sources